Published on April 16, 2008
Exhibit
23.2
CONSENT
OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
To
the
Board of Directors
Novelos
Therapeutics, Inc.
We
consent to the use of our report dated March 17, 2008 relating to the financial
statements of Novelos Therapeutics, Inc. as of December 31, 2007 and 2006 and
for each of the two years then ended, in this Post-Effective Amendment on Form
S-1 to the Registration Statement on Form SB-2 (No. 333-143263) of Novelos
Therapeutics, Inc., relating to the registration of 12,000,000 shares of common
stock.
We
also
consent to the use of our name and the reference to us in the “Experts” section
of this registration statement.
|
/s/
Stowe & Degon
|
|
Worcester,
MA
|
|
April
15, 2008
|